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GENERAL INTRODUCTION 
Infection with respiratory syncytial virus (RSV) is common in man 
and ruminants, 6,28,54 Antigenically RSV isolates from humans and 
animal species are heterologous when examined by neutralization 
kinetics, but all are closely related and are regarded as a single 
serotype. Subtypes of human isolates are identified using kinetic 
serum neutralization tests, monoclonal antibodies in immunofluorescent 
and radio immunoprecipitation assays.For the purposes of this 
thesis , in the literature review no distinction is made between 
isolates. 
Bovine respiratory syncytial virus (BRSV) is common in 
CO-infections with other respiratory pathogens such as 
parainfluenzavirus 3 and Pasteurella hemolvtica but BRSV is often the 
sole agent associated with acute fatal bronchointerstitial pneumonia in 
weanling cattle.The incidence of disease associated with 
BRSV infection in cattle is unknown but is much less than the incidence 
of BRSV infection, which is 60-80%.^ 
Two hallmarks of RSV infections are recurrence and marked 
variability in disease associated with infection. Atypical 
interstitial pneumonia can result from BRSV infections in weanling 
cattle. Atypical interstitial pneumonia is characterized 
2 
histologically by severe necrotizing bronchiolitis, interstitial 
pneumonitis with Type II pneumocyte hyperplasia, hyaline membranes and 
emphysema.Experimental infection of neonatal calves and lambs 
with BRSV produces necrotizing bronchiolitis, interstitial pneumonitis 
and pneumonia with lymphocytic peribronchiolar and septal infiltrates 
and exudates of neutrophils, lymphocytes and macrophages. 
The inability to produce atypical interstitial pneumonia by 
experimental infection with BRSV could result from: attenuation of 
BRSV during laboratory isolation,multiple subtypes of BRSV which 
vary in virulence ^ ^ ' 28,41 co-infections in animals with 
atypical interstitial pneumonia,and immunopathological 
reactions caused by natural infections with BRSV that have not been 
duplicated experimentally.Evidence supporting any 
one of these proposals is either lacking or inconclusive. 
The composition of respiratory secretions and epithelial lining 
11 99 
varies with location within the respiratory tract. ' These 
variations are responsible for disparity within the respiratory tract 
regarding susceptibility to insults. Most of the staining for BRSV in 
15 17 infected cattle is within bronchial epithelium. ' Staining for 
BRSV antigen in experimentally infected sheep is located primarily in 
bronchiolar and alveolar epithelium.The establishment of 
infection is a critical event in any infectious disease. In reports of 
cattle and sheep experimentally infected with BRSV, the earliest time 
period post-inoculation (P.I.) for which lesions and antigen location 
are described is 2 days.Several viral replication 
3 
cycles can occur in a 2 day time period and secondary foci of infection 
may be established.^^ 
The sites of initial infection within the lung can be determined if 
tissues are examined at a time interval P.I. that is too brief to allow 
replication and dissemination of virus. Respiratory syncytial virus 
replicates in approximately 12 hours in cell culture.This 
dictates that to determine the site of initial infection, tissues must 
be examined for antigen between 12-24 hours P.I. Antigen detected 
after 24 hours P.I. could represent secondary foci of infection. The 
goals of this study were to i.) determine cell types in the ovine lung 
that were the first to stain for BRSV antigen, both in infected sheep 
and in sheep lung slices inoculated in vitro. ii.) examine the 
chronological progression of infection and development of lesions. 
To obtain these goals, the project consisted of the following two 
steps; first, develop immunocytochemical techniques for detecting BRSV 
antigen in fixed-processed tissues at the light and electron 
microscopic levels, second, apply these techniques to lung tissues 
from infected sheep and to sheep lung tissues that were infected in 
vitro. 
Sheep were chosen as the experimental animal because BRSV causes 
31 
upper respiratory disease in sheep and lung lesions are produced by 
experimentally infecting sheep with BRSV.^5,89 hope to develop 
BRSV infection in sheep as an experimental model for BRSV infection in 
cattle and humans. Sheep are more easily handled than cattle and less 
expensive. In addition, sheep are susceptible to infection with many 
4 
viral agents that are pathogenic to cattle. Susceptibility to the same 
viral pathogens will allow examination of the role of viral co-infec­
tions in ruminant respiratory disease. 
The sheep were infected by flooding the right cranial lobe of the 
lung with BRSV. This method of inoculation was chosen to insure 
exposure of sampled lung tissue to virus and to infect high numbers of 
cells. To determine whether BRSV has a tropism for a particular 
epithelial cell type widespread infection is necessary to allow 
morphometric analysis. Two important differences between our study and 
previous studies are: detection of BRSV antigen at a time interval of 
less than 2 days P.I., and use of an immunoperoxidase technique for 
detection of BRSV antigen in fixed tissues. The immunoperoxidase 
technique is more sensitive than the immunofluorescent technique^^' 
used by most previous authors. 
This dissertation is presented in the alternate format and consists 
of 2 manuscripts prepared for submission to refereed scientific 
journals. The format is that of "Veterinary Pathology". A literature 
review precedes the first manuscript. The first manuscript is 
published in "Veterinary Pathology", and the second manuscript will be 
submitted to "Veterinary Pathology". A general summary and discussion 
follows the last manuscript. A list of references is presented at the 
end of each manuscript. Literature cited in the introduction, 
literature review, general summary and discussion is presented at the 
end of the dissertation. 
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Members of the National Animal Disease Center - National 
Veterinary Services Laboratory Animal Care and Use Committee reviewed 
the protocol for this project and concluded that animals would be 
humanely treated in this research. 
The Ph.D. candidate, James Toby Meehan, was the principal 
investigator. 
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LITERATURE REVIEW 
There is much interest in RSV because of the prevalence of infec­
tion among humans and ruminants, the disease caused by RSV being 
particularly severe in neonatal and weanling animals. 
Althou^ RSV infection and disease does not naturally occur in 
laboratory animals such as rats and mice, much of the information 
regarding RSV infection has been obtained by experimentally infecting 
these species with RSV. Extensive reviews of RSV infections in humans 
and ruminants and of the virus recently have been published. 
This review is limited primarily to RSV infection in ruminants. The 
involvement of RSV infections in establishing secondary bacterial 
bronchopneumonias will be mentioned briefly. 
Respiratory svncvtial virus 
Respiratory syncytial virus infection is prevalent in humans and 
33 
ruminants. Infection with RSV causes coryza, bronchiolitis, 
interstitial pneumonitis and pneumonia,29,54 Respiratory syncytial 
virus is a negative sense, single-stranded RNA virus of the genus 
qo 
Pneumonovirus in the paramvxoviridae family. The -paramvxoviridae 
family has many members, including pneumoviruses (RSV, pneumonia virus 
of mice), paramyxoviruses parainfluenzavirus-3, Sendai virus, New 
Castle Disease virus, mumps virus), and morbilliviruses (measles virus, 
Q q 
canine distemper virus, rinderpest virus). 
7 
With the exception of RSV, which lacks a hemagglutinating glycopro­
tein, members of Paramvxoviridae have characteristic hemagglutination 
(H or HN) and fusion (F^) glycoproteins associated with their 
envelopes. Characteristics of these glycoproteins vary among viral 
genera. For example, the hemagglutinin (HN) of paramyxoviruses has 
both hemagglutinating and neuraminidase activity, whereas the 
hemagglutinin glycoprotein (H) of morbilliviruses has no neuraminidase 
activity. 
Respiratory syncytial virus also differs from other members of 
Paramvxoviridae in its number of genes (10 compared to 6 or 7 for other 
paramyxoviruses) and its gene order. These differences are evidenced 
by several proteins in RSV, in particular the G glycoprotein, which are 
distinct from proteins of other paramyxoviruses,,54 Glycoproteins 
G and F^ of RSV are envelope-associated. Glycoprotein G is 
extensively glycosylated, which is unusual for a paramyxovirus, and is 
responsible for viral attachment to the host cell membrane. The 
FQ glycoprotein of RSV differs from fusion proteins of other 
paramyxoviruses in that its amino terminus is extracellular and the 
carboxyl terminus is intracellular.^^ The F^ glycoprotein is 
cleaved intracellularly by a host cell protease to form the 
disulfide-linked subunits F^ and The F^ and F2 
subunits are essential for fusion of viral envelope with the host cell 
membrane. This fusion results in infection and syncytia formation. 
The M protein is a structural protein associated with the inner portion 
of the viral envelope and the N protein is a nucleocapsid protein. 
8 
Immune responses are directed against the G, , N and M proteins of 
RSV.59'93 Cell-mediated immunity is directed in part against the N 
protein.Antibodies to the and G glycoproteins and the M 
protein are neutralizing^^,59,82 the F^ glycoprotein 
possessing more neutralizing epitopes than the G glycoprotein. 
Respiratory syncytial virus is a monotypic strain virus with iso­
lates from all host species (ovine, bovine, caprine, human) 
cross-reacting on serum neutralization and immunofluorescence 
tests.Using monoclonal antibodies and kinetic serum neutraliza­
tion tests, human isolates are characterized as subtypes Â or 
1 S8 81 Q1 
B. ' ' ' Subtypes are based on differences in the G glycopro­
teins. The composition of the G glycoprotein also differs in 
composition between isolates but F^ is highly conserved and 
contributes to cross-reaction between subtypes and isolates. 
Subtypes of bovine RSV have not been described. 
As with other paramyxoviruses, infection with RSV is spread to 
non-infected cells by virions budding from cell membranes and by fusion 
of infected cells with adjacent noninfected cells. Respiratory 
syncytial virus virions are highly pleomorphic and bud as either round 
or filamentous particles (100 nm x 1-4 pm) from the apical 
membranes of infected cells (Figure 1).^'^^ Respiratory syncytial 
virus is fastidious and highly cell-associated with up to 90% of the 
virus being cell-associated during an infection. 
9 
Epidemiology of respiratory syncytial virus infection 
Respiratory syncytial virus was initially isolated from the upper 
respiratory tract of chimpanzees in 1956.In 1957, the virus was 
19 isolated from a human infant with croup. Serological evidence 
obtained in 1968 demonstrated RSV infection in cattle and the virus was 
isolated from cattle in 1970.^^'^^ Serological evidence for RSV 
7 96 infection in sheep was presented in 1973, ' and isolation of RSV 
c n 
from sheep was reported in 1984. Respiratory syncytial virus has 
77 78 
also been isolated from goats and wild bighorn sheep. ' ' ' 
Serological evidence indicates that horses, swine, dogs, and cats are 
70 
also susceptible to infection with RSV. Respiratory syncytial 
virus infection is prevalent in cattle and sheep from many countries, 
with 60-80% of these species being seropositive.^'^ However, the 
incidence of respiratory disease caused by RSV infections in cattle and 
sheep is not known.^ In cattle herds infected with RSV, morbidity 
C  Q O  
often approaches 100%. ' Mortality is variable and can be as high 
as 20%.^ Disease resulting from RSV infection in cattle is most 
common among calves in fall and winter seasons .^ Severe cases of 
respiratory disease caused by RSV infection is associated with animals 
on high energy diets. 
Transmission of respiratory syncytial virus 
Respiratory syncytial virus can be transmitted by direct contact, 
38 
aerosol, and fomites. However, the predominant mode of 
00 
transmission of RSV among animals is unknown. Respiratory 
10 
syncytial virus is very labile and survives only a matter of hours on 
O Q  71 
fomites and in aerosolized droplets. However, these routes of 
transmission could be significant among closely housed animals. Experi­
mental infection can be initiated by inhalation of virus and by 
og 
inoculation of conjuctiva with virus. 
Natural respiratory syncytial virus infection 
The hallmarks of RSV infections include recurrence^^'^^ and vari­
ability of associated disease. In cattle, reinfection with RSV has 
been observed as early as 3 weeks after the initial infection. The 
one report of natural RSV infections in sheep describes a mild 
31 
conjunctivitis in lambs with no clinical signs of pneumonia. Cattle 
infected with respiratory syncytial virus are often concurrently 
infected with other pulmonary pathogens such as parainfluenzavirus 3, 
Pasteurella hemolvtica. Pasteurella multocida. Mycoplasma bovis. and 
Haemophilus somnusH o w e v e r ,  R S V  i s  c o m m o n l y  t h e  s o l e  a g e n t  
93 
associated with enzootic pneumonia in young calves and atypical 
C  A O  
interstitial pneumonia in yearling calves. ' Natural infections 
with RSV in cattle can be asymptomatic, cause mild upper respiratory 
tract disease characterized by lacrimal discharge, nasal discharge, 
5 28 
coughing, and hyperpnea, or cause severe pneumonia. ' In some 
cattle herds infected with RSV, two stages of the respiratory disease 
c oo 
have been described. ' First, mild respiratory disease, 
characterized by nasal and lacrimal discharge, occurs and is followed 
by recovery. Then, within several days, there is a sudden 
11 
onset of severe dyspnea leading rapidly to death as a result of 
atypical interstitial pneumonia. 
There are no reports of lesions in sheep caused by natural infec­
tion with RSV. Gross lesions caused by natural infections with RSV in 
cattle include atelectasis and consolidation of the cranioventral por­
tions of the lung, failure of the lungs to collapse when the thoracic 
cavity is opened, septal and subpleural edema, and interstitial and 
subpleural emphysema involving the caudodorsal portions of the 
lung.^'^^'^^'^^r^^ In severe disease, emphysema extends into the 
mediastinum and into subcutaneous tissues of the back and neck. If 
there is secondary bacterial infection, fibrinous pleuritis and broncho­
pneumonia may be present. 
No histological lesions have been reported in sheep naturally in­
fected with RSV. Histological lesions caused by natural infection of 
cattle with RSV are characterized by bronchiolitis with necrosis of the 
bronchiolar epithelium and accumulation of inflammatory cells and 
debris within bronchiolar lumens. There is atelectasis and alveoli 
contain lymphocytes, macrophages, neutrophils and fibrin. There is 
interstitial emphysemia and pneumonitis with accumulation of 
lymphocytes, plasma cells and macrophages in peribronchiolar regions 
5 18 
and alveolar septa. ' Syncytial cells are prominent within 
bronchioles and alveolar spaces. Bronchiolar epithelium often contains 
eosinophilic intracytoplasmic inclusion bodies.Tracheitis and 
bronchitis are also present. Atypical interstitial pneumonia caused by 
natural infection with RSV has in addition to the above changes; 
12 
extensive Type II pneumocyte hyperplasia, hyaline membranes, and 
alveolar edema. When RSV infection in cattle is complicated with 
secondary bacterial infection, a fibrinopurulent bronchopneumonia is 
present. 
Diaenosis of respiratory syncytial virus infection 
Immunohistochemistry is the most dependable method for positive 
identification of RSV in infected tissue.Fluorescent antibody 
staining of frozen lung tissue or nasal exudate is used in most 
diagnostic laboratories. In outbreaks of RSV infection in cattle, 
there can be atypical interstitial pneumonia, without detectable 
antigen by immunohistochemical techniques.Failure to detect viral 
antigen using immunohistochemical techniques may result from RSV 
antigen in the tissues being bound by the host antibody.^Indeed, 
RSV is rarely isolated from lung tissue of naturally infected 
cattle.^This infrequent virus isolation may result from both 
neutralizing antibody and the fastidious nature of the virus. 
Making a definitive diagnosis of RSV infection based on serology is 
often difficult.A diagnostic fourfold difference in 
anti-RSV titer between the initial and convalescent stages of disease 
is seldom detected because clinical signs are often not noticed until 
several days following infection. In young calves, maternal antibodies 
against RSV suppress immune responses to the virus. 
13 
Experimental respiratory syncytial virus Infection 
Respiratory syncytial virus infections have been produced experimen­
tally in calves, lambs, cotton rats, ferrets, mice, and non-human pri­
mates.Cross-infectivity among species and 
r e s u l t a n t  m i c r o s c o p i c  l e s i o n s  c a n  b e  d e m o n s t r a t e d . A s  
in animals naturally infected with RSV, lesions are variable but less 
severe. The severe lesions seen in yearling calves naturally infected 
with RSV have not been experimentally reproduced. Lung lesions 
resulting from experimental RSV infection vary with species, 
inoculation regimen, and age of the animals. Neonatal animals, 
experimentally infected with RSV, generally have more extensive and 
severe lesions than adolescent or adult animals. Laboratory rodents 
experimentally infected with human RSV have no gross les-
Lambs (1 week-6 months old) infected with RSV 
develop minimal gross lesions consisting of foci throughout the lungs 
of hemorrhage and consolidation less than 1 cm in diameter. 
There are no reports of yearling cattle experimentally infected with 
RSV. Neonatal calves experimentally infected with RSV have atelectasis 
and consolidation of the cranioventral portions of the lung. 
Among the many animals experimentally infected with RSV, emphysematous 
lesions have only been reported in one neonatal colostrum-deprived 
calf.15 
14 
Microscopic lesions vary in animals experimentally infected with 
RSV. Respiratory syncytial virus infection in laboratory rodents 
causes minimal rhinitis, bronchitis, bronchiolitis and interstitial 
pneumonitis with peribronchiolar and perivascular infiltrates of 
lymphocytes and macrophages; syncytia are scarce or 
absent.Epithelial necrosis and exudate in airways and 
alveoli are not prominent. In neonatal to 6-month-old lambs infected 
experimentally with RSV, there is minimal to moderate multifocal 
necrotizing bronchiolitis and interstitial pneumonitis and pneumonia 
characterized by bronchiolar epithelial necrosis with peribronchiolar 
and alveolar septal infiltrates of lymphocytes and macrophages.^5,89 
Terminal bronchioles and alveoli contain cell debris and exudate 
composed of neutrophils, lymphocytes, macrophages and RBCs. There is 
O C  
Type II pneumocyte hyperplasia several days post-infection. The 
severity of lesions in neonatal calves experimentally infected with RSV 
varies.In one report the lesions are moderate with 
bronchitis and bronchial epithelial necrosis being predominant. There 
is also rhinitis, tracheitis and bronchiolitis with epithelial necrosis 
and accumulations of neutrophils, macrophages and mononuclear 
inflammatory cells within bronchioles and extending into alveoli 
adjacent to affected bronchioles.^^ Similar but more extensive 
lesions are described in another report of cattle experimentally 
infected with RSV in which there is bronchitis, bronchiolitis and 
pneumonia with bronchiolar epithelial necrosis and extensive areas of 
pneumonia. Airway and alveolar exudate consisted of neutrophils and 
15 
mononuclear inflaimnatory cells. Several days post-inoculation there is 
pronounced brohchiolar and alveolar epithelial hyperplasia.Unlike 
lesions in sheep,25,89 experimental infection of calves with RSV 
produces prominent syncytia within bronchiolar epithelium and alveolar 
s p a c e s . T h e r e  i s  e v i d e n c e  t h a t  s y n c y t i a  r e s u l t  f r o m  f u s i o n  
17 53 
of both epithelial cells and alveolar macrophages. Also 
present in experimentally infected neonatal calves are intracytoplasmic 
inclusion bodies within epithelial and syncytial cells.One 
proposed explanation for the variation in lesions produced by 
experimental infection in calves is differences in virulence of the RSV 
isolates used for inoculation.^^ 
Location of RSV antigen in experimental infection varies between 
calves and lambs in a manner similar to the lesion distribution in 
these species. Respiratory syncytial virus antigen in experimentally 
infected weanling and neonatal lambs is located primarily in 
bronchiolar epithelium and as determined by immunofluorescent 
techniques.^5,88 virions are seen in association with bronchiolar 
95 QQ 
epithelium and Type I pneumocytes in lambs. • Neonatal calves 
experimentally infected with RSV have viral antigen throughout the 
respiratory tract, although viral antigen is most common within the 
15 17 87 bronchial epithelium. ' ' Virion buds and nucleocapsid protein 
are seen within bronchiolar epithelium. Virions and viral proteins are 
more often associated with ciliated cells than mucous or Clara 
cells.Neither virions or nucleocapsids have been reported in 
association with alveolar epithelium of experimentally infected 
16 
calves, although RSV antigen is detected in alveolar septa using 
immunofluorescence techniques. 
Immunity to respiratory syncytial virus 
Protection against infectious agents in the upper respiratory tract 
of ruminants is provided by locally produced secretory IgA.^^ Protec­
tion against infectious agents within the lung is provided primarily by 
IgG-1 of humoral origin, the primary immunoglobulin in colostrum of 
ruminants.Passive immunity provides protection against RSV infec­
tion in cattle.This protection is evidenced by the low inci­
dence of respiratory disease caused by RSV infection in nursing 
calves. However, natural infection with RSV causes severe respiratory 
disease in previously vaccinated yearling calves.In one report 
RSV infection caused severe disease in calves which had anti-RSV IgG-1 
in their lungs, but lacked anti-RSV IgA.^^ This report indicates 
that immunity to RSV infection is inadequate in calves possessing 
anti-RSV IgG-1, which should be protective in the lung. Indeed, some 
authors suggest that during RSV infection, immunopathologic mechanisms 
may contribute to severe atypical interstitial pneumonia. 
In general, cell-mediated immunity plays an important protective role 
O O  Q O  
in viral infections. ' Cattle infected with RSV or vaccinated 
with modified live or killed vaccines show RSV-specific 
lymphoblastogenesis indicative of a possible role of cell mediated 
immunity in protection against RSV infections. There is no correlation 
between lymphoblastogenic responses and levels of anti-RSV antibodies 
indicating that these two responses may be induced by independent 
17 
epitopes on RSV.^® The roles of cell-mediated and humoral responses 
in immunity to RSV infections in cattle is yet undetermined. 
Pathogenesis of respiratory syncytial virus infection 
Factors that dictate recurrence of infection and severity of respi­
ratory disease in RSV infections in cattle are not resolved. Respira­
tory syncytial virus infection of a macrophage cell line stimulates the 
production of IL-1 inhibitor by the infected macrophages.^^ This 
IL-1 inhibitor could suppress local anamnestic immune responses and 
leave the respiratory mucosa susceptible to reinfection.^^ 
The severe respiratory disease that is produced in cattle naturally 
infected with RSV cannot be reproduced experimentally. This indicates 
that additional unknown factors contribute to the severe respiratory 
disease associated with RSV infection in cattle. Factors to be consid-
1 9  7?  
ered must include; co-infections with other viral pathogens, ' 
multiple strains of RSV with variations in virulence among 
strains,immunological components_^»^8,68 and variations in 
pulmonary; structure (epithelial cell types), function (elasticity) and 
cell metabolism. 
Co-infections with pulmonary pathogens can have synergistic 
0 19 og 
effects. ' ' The combination of parainfluenzavirus-3 and RSV 
infections causes severe respiratory disease in cattle. 
There is speculation on the role of bovine viral diarrhea virus (BVDV) 
in severe respiratory disease in cattle naturally infected with 
18 
RSV.^2 Co-infections of BVDV/RSV have not been extensively studied 
and data are not supportive of a synergism (personal communication with 
Lehmkuhl and Bolin). Combined infections of Mycoplasma bo vis and 
RSV in gnotobiotic calves caused no more severe lesions than when each 
Q  C  
agent was used independently to infect calves. 
Some viral agents become attenuated during laboratory isolation 
33 procedures and in vitro propagation. Attenuation may be the reason 
that experimental infection with RSV does not cause severe disease. 
However, there is no evidence of altered virulence among RSV isolates 
Immunological components may contribute to severe respiratory dis­
ease in cattle infected with RSV. Type III hypersensitivity is one 
proposed mechanism.It has been postulated that some calves 
are sensitized to non-neutralizing epitopes, particularly on the 
and G viral glycoproteins, by natural infection or vaccina­
tion.The response to subsequent infection would be 
preferential production of non-neutralizing antibodies, the formation 
of antigen-antibody complexes, and subsequent initiation of an Arthus 
reaction resulting in vascular damage.Data from one clinical 
study of calves (ages 2 weeks to 7 months) with RSV associated respira­
tory disease found that severe respiratory disease occurred in calves 
which had high serum levels of anti-RSV IgG-1.^^ Pulmonary 
arterioles in these calves had minimal intimai swelling and 
perivascular edema. The authors interpreted these changes as 
indicative of an Arthus reaction.^4,46,47 using immunofluorescent 
techniques, complement component 3 was detected among cells in the 
19 
bronchioles and alveoli of these calves.These data are 
inconclusive with regards to the role of Arthus reactions in RSV 
infections. The histologic changes characteristic of Arthus reactions 
are not a prominent component of lesions caused by natural infection of 
cattle with RSV. Type I hypersensitivity has been postulated to cause 
92 
severe respiratory disease in RSV infections in humans. This idea 
is supported by the presence of high IgE levels in nasal secretions of 
individuals severely affected by RSV infection. Assessment of the role 
of classes of immunoglobulins in RSV induced disease in cattle is 
difficult because of the inability to produce severe disease with 
experimental infection. Data is suggestive of a correlation between 
secretory IgE levels and disease severity in RSV infected cattle but 
80 inconclusive. Levels of IgA and IgG do not correlate with severity 
of clinical signs in cattle experimentally infected with RSV.^^ 
Assessment of the role of inflamnatory mediators in severe disease 
caused by RSV infections is likewise difficult because of the inability 
to produce severe disease with experimental infections. However in 
experimentally infected cattle the is a correlation between thromboxane 
B2 levels and severity of clinical disease. A trend exists 
between disease severity and plasma prostaglandin levels but a 
statistical correlation is lacking. 
Anatomical factors may also contribute to the severity of disease 
caused by RSV infections. Neonates also have increased closing volumes 
and higher metabolic rates than adults, but the lung surface area to 
body weight ratio is similar between neonates and adults.These 
20 
characteristics decrease the respiratory reserve of a neonate in 
comparison to an adult. Therefore, neonates are less able than adults 
to compensate after a respiratory insult. The above mentioned 
differences between neonate and adult lungs may contribute to the 
severe respiratory disease caused by RSV in neonatal calves, but fails 
to explain the severe respiratory disease caused by RSV infection in 
yearling cattle. 
The ability of a pathogenic agent to affect a particular cell popu­
lation is a major determinant of disease severity and lesion 
c "I Q no 
distribution. ' ' For a particular cell population to be infected 
with RSV, the virus must gain access to the cells, attach, and 
replicate. For most paramyxoviruses, absorption is not a selective 
factor in establishing infection. However, the selectivity of the 
G glycoprotein of RSV, with regard to cellular absorption is not known 
but could be a selective factor in determining cell types in the lung 
which can support RSV infection. Cleavage of the F^ glycoprotein to 
the F^ and F2 subunits by a host cell protease is a critical event 
in RSV infection because it brings about fusion of the viral envelope 
and host cell membranes.This fusion allows viral nucleic acids 
and proteins to enter the host cell. Cells lacking the necessary 
protease(s) for cleavage are resistant to RSV infection.The 
respiratory tract epithelium is comprised of a diverse population of 
specialized cells.In cattle, no specific cell population(s) has 
been identified as being preferentially infected in animals with severe 
respiratory tract disease caused by RSV infection. 
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Immunohistochemistrv 
Immvinohistochemistry (inmunocytochemistry) was first used by Coons 
et al. in 1942 to detect bacterial antigens. Direct 
immunohis tochemi s try consists of labeling a primary antigen-specific 
antibody with a marker. Indirect immunohistochemistry makes use of a 
labelled secondary antibody directed against a primary antigen-specific 
antibody (Figure Indirect techniques greatly increase 
the versatility of immunohistochemistry because they eliminate the 
necessity to conjugate a marker to each different antigen-specific 
primary antibody. Moreover, indirect immunohistochemical techniques 
increase the sensitivity of antigen detection.The first markers 
used to label antibodies for use in immunohistochemistry were 
fluorescent dyes. The autofluorescence of aldehyde groups in fixed 
tissues limits the use of immunofluorescent techniques primarily to 
frozen tissue sections. The cellular detail in frozen sections is 
greatly compromised so that antigen location and detailed 
histopathological evaluation cannot be assessed in the same tissue 
section. The use of immunoenzyme and immunogold histochemical 
techniques allows antigen detection in fixed processed tissues. 
Cellular detail is maintained in these tissues so that antigen 
detection and histopathology can be assessed in detail in the same 
tissue section. 
The primary objective of immunohistochemistry is antigen detection 
with an optimized signal to noise ratio.Antigen detection 
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is dependent upon antigen availability in the tissue. An antigen can 
be unavailable if it is either destroyed or altered during fixation and 
processing of the tissue. The term "masked" is used to describe 
antigens which are altered and rendered undetectable, but not 
destroyed, by fixation and processing of tissues.Masked antigens 
most likely result from cross-linking of membranes during 
fixation.If an antigen is destroyed by tissue fixation and 
processing, frozen sections are often the only suitable samples for 
immvmohistochemistry. As previously mentioned, cellular detail is 
greatly compromised in frozen sections. Masking of antigens may be 
overcome by enzymatic digestion or detergent disruption of cross-linked 
membranes.Respiratory syncytial virus antigens are masked in 
tissues fixed and processed for light and electron microscopy. Enzy­
matic digestion has been used in immunohistochemical techniques to 
unmask RSV antigen for detection at the light microscopic level. 
Enzymatic digestion causes minimal to moderate loss of cellular detail 
at the light microscopic level but the ultrastructural detail would be 
greatly compromised. 
Problems of performing iimnunohistochemistry at the ultrastructural 
level are compounded by effects of fixation and processing procedures 
which optimize structural preservation but preclude antigen detec-
O  C Q  
tion. ' Protocols for maintaining both ultrastructural integrity 
and antigen availability are numerous. They include: use of fixatives 
with modified cross-linking abilities, pre-embedding immunohistochemi­
cal staining of tissues, etching of epon-embedded thin sections and 
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resin removal from thin sections prior to labeling. All of these proce­
dures compromise structural integrity and/or definition. The quest to 
obtain one ideal fixation and processing technique has been fruitless. 
"The beauty of the fixative will be in the eyes (of antibodies) of the 
beholder."^® The investigator must weigh ultrastructural 
preservation against antigen identification and decide at what point 
the loss of ultrastructural detail outweighs the benefits of antigen 
identification. To date, there are no reports of RSV being labeled at 
the electron microscopic level. Respiratory syncytial virus 
identification at the electron microscopic level is dependent upon 
morphology which can be difficult at times because of RSVs pleomorphic 
nature and resemblance to microvilli. 
Figure la. Ovine fetal turbinate cells infected with RSV. 
Virions (arrow) and viral buds (arrowhead). 
Bar — 2 urn 
Figure lb. Ovine fetal turbinate cells infected with RSV. Same 
field as figure la higher magnification. Virion (black 
arrow) and viral buds (black arrowhead) are identified 
by electron dense layer opposed to inner side of 
membrane and nucleoproteins (white arrow). Bar =-
250 nm. 
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Figuré 2. Schematic of direct and indirect immunohistochemical 
techniques, a -antigen, o-marker-primary antibody, 
^ -secondary antibody 
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ABSTRACT 
The efficacy of protease and EDTA-Tween 20 in unmasking bovine 
respiratory syncytial virus (BRSV) antigens in formalin fixed lung 
tissue was compared using avidin-biotin immunoperoxidase procedure. 
Tissues were from experimentally infected lambs. BRSV antigen stained 
in both techniques. Treatment with EDTA-Tween 20 resulted in more 
intense staining of BRSV infected cells, more uniform cytoplasmic 
staining, less non-specific background and superior cellular detail in 
comparison to protease digestion. 
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INTRODUCTION 
Respiratory syncytial virus (RSV) is a common cause of respiratory 
disease in both humans and livestock.Infection can result 
in a severe necrotizing bronchiolitis and pneumonia, which are seen 
n 1 c 
more frequently among immature than mature animals. ' Respiratory 
syncytial virus is a fastidious virus. Histologic lesions allow only a 
presumptive diagnosis of bovine respiratory syncytial virus (BRSV) 
pneumonia since parainfluenzavirus 3 can cause similar lesions.^ 
Until recently, histological detection of BRSV was done only with 
fluorescent antibody test on unfixed tissue. 
Immunohistochemical techniques using fixed tissue greatly 
facilitates BRSV diagnosis by allowing identification of specific cell 
types infected and tissue changes. Recently BRSV antigen detection in 
fixed tissue has been demonstrated with immunoperoxidase techniques 
using a monoclonal antibody against BRSV or protease digestion in 
combination with anti-BRSV rabbit antisera.^'^^ Protease tissue 
digestion, while unmasking some antigenic sites, destroys others and 
O 
causes noticeable tissue damage. In this study we compare protease 
digestion with detergent treatment for unmasking BRSV antigen in fixed 
tissue sections. 
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MATERIALS AND METHODS 
Yearling sheep were inoculated intratracheally with 20 ml of BRSV 
19 375 inoculum for 2 consecutive days (total 40 ml). The sheep were 
killed on postinoculation day 5 and lung tissue was fixed by submersion 
and stored in 10% neutral buffered formalin for 4 days, processed 
routinely and embedded in paraffin at 60°C. Additional tissue was 
fixed by submersion in 4% paraformaldehyde in O.IM cacodylate buffer 
for 24 hr and in 2.5% glutaraldehyde in O.IM cacodylate buffer for 12 
hr. Tissues were stored in O.IM cacodylate buffer prior to paraffin 
embedding. Sections of 3 fim thickness were put on poly-L-lysine 
coated glass slides, deparaffinized with three changes of xylene, 
rehydrated through graded acidified alcohol baths (0.5 ml concentrated 
HC1/250 ml) and taken to distilled water. At this point the sections 
were subjected to one of two treatments prior to staining for BRSV 
using an immunoperoxidase ABC procedure^. One treatment involved 
protease digestion of the sections, the other was adapted from a 
technique in which the sections are washed with a buffer containing 
EDTA and Tween 20^®'^^ The primary antibody in both techniques was 
rabbit antisera made to the whole virus (Dr. C. Kucera, Norden Lab., 
Inc., Lincoln, NE) and the remaining immunoperoxidase reagents were 
obtained commercially (Vectastain ABC Kit, Vector Lab., Burlingame, CA) 
and used at identical concentrations on all sections. 
The technique employing EDTA and Tween 20, was as follows. After 
rehydration endogenous peroxidase activity was eliminated by 
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submerging the sections in freshly prepared 1% H2O2 in absolute 
methanol for 30 minutes. The tissues were then rinsed by submersion 
for three 5 minute periods in 0.05M Tris buffered saline (TBS) pH 7.6 
after which they were submersed in TBS-EDTA-Tween buffer pH 7.6 (TBS 
with ImM EDTA and 0.05% Tween 20) and incubated for 10 minutes. The 
sections were then flooded with undiluted normal goat serum (blocking 
serum) and incubated for 15 minutes at 37°C in a humidified chamber. 
The blocking serum was blotted off and primary rabbit anti-BRSV 
antiserum, diluted 1:1000 in TBS, was applied by flooding each section 
after which they were incubated at 4°C overnight in a humidified 
chamber. The sections were then rinsed by submersion for three 5 
minute periods in TBS-EDTA-Tween buffer. Next the sections were 
flooded with biotinylated goat anti-rabbit antisera diluted 1:100 in 
TBS and incubated at 37°C for 60 minutes in a humidified chamber. 
The sections were then rinsed by submersion for three 5 minute periods 
in TBS-EDTA-Tween buffer. After rinsing the sections were flooded with 
ABC reagent, diluted 1:100 in TBS-EDTA-Tween buffer and incubated for 
60 minutes at 37°C in a humidified chamber. Following ABC 
incubation, the sections were rinsed for one 5 minute period by 
submersion in TBS-EDTA-Tween buffer, followed by two 5 minute rinses 
with TBS. The sections were then incubated with freshly made DAB 
substrate for 10 minutes at room temperature in a humidified chamber, 
followed by a 5 minute rinse with running tap water. All sections were 
counter stained with Mayers hematoxylin. 
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The protease digestion technique was as follows.^^ After 
rehydration, endogenous peroxidase activity was eliminated by 
submerging the sections in freshly prepared 1% H2O2 in absolute 
methanol for 30 minutes. Tissues were then rinsed with tap water for 5 
minutes. Next protease digestion was carried out for 10 minutes at 
37°C by flooding each section with a solution of 1% protease 
(Protease XIV, Sigma Chem. Co.) made up in TBS pH 7.6. Tissues were 
then washed by submersion for three 5-minute periods in TBS. The 
sections were then flooded with undiluted blocking normal goat serum, 
as described for the Tris-EDTA-Tween technique. From this point on, 
the protease and Tween treated sections were treated identically, with 
the exception that for the protease technique all rinses were carried 
out and reagents made up using only TBS. 
Negative controls consisted of a) substitution of normal rabbit 
sera for the primary antibody b) substitution of TBS for primary 
antibody and c.) staining of adenovirus infected sheep lung tissues. 
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RESULTS 
Histological changes in the infected tissues were characterized by 
moderate multifocal purulent bronchiolitis with epithelial sloughing, 
syncytia formation and mild alveolar septa thickening. Specific 
staining of infected cells was obtained with both methods. In all 
sections, infected cells consisted of sloughed and intact bronchiolar 
epithelium, alveolar macrophages and occasionally syncytia. 
The two staining techniques were compared by staining paired 
adjacent sections (Fig.s la & b through 3a & b). Protease digestion, 
prior to staining, resulted in peroxidase labeling of infected cells 
primarily along the cell's periphery and of perinuclear cytoplasmic 
inclusions, not detectable on routine H & E sections (Figs, lb & 2b). 
A diffuse background staining, not extensive enough to interfere with 
recognition of infected cells, was present throughout the parenchyma 
and airspaces in the sections exposed to protease digestion. The loss 
of cellular detail resulting from protease digestion is evident by the 
lack of cilia on the airway epithelium (Fig. 3b). 
Sections that were treated with TBS-EDTA-Tween buffer had intense 
antigen staining distributed throughout the cytoplasm of infected 
cells. Cytoplasmic inclusions were not evident (Figs, la & 2a). 
Instead, many of the antigen positive cells contained cytoplasmic 
vacuoles (Fig. 2a). Cellular detail was preserved with cilia easily 
visualized (Fig. 3a). In some cells the staining of viral antigens was 
most intense along the cilia (Fig. 3a), and apical portions of the 
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cell. There was no diffuse background staining (Figs. 2a & 3a). The 
TBS-EDTA-Tween technique resulted in more intense and uniform staining 
of a greater number of cells than the protease technique. 
BRSV antigen stained in paraformaldehyde and glutaraldehyde fixed 
tissues. However, glutaraldehyde fixed tissues stained much less 
intensely than either formalin or paraformaldehyde fixed tissues. 
All negative controls had no peroxidase staining. 
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DISCUSSION 
In our laboratory the use of TBS-EDTA-Tween buffer technique for 
detection of BRSV infected cells in fixed processed tissues was 
superior to protease digestion for the following reasons: 1) intensity 
and homogeneity of cytoplasmic staining was greater; 2) diffuse 
background staining was not present; 3) infected cells were more easily 
distinguished from adjacent non-infected cells; and 4) there were fewer 
adverse effects on cellular morphology. 
Tween 20 acts to unmask antigenic sites in fixed cell membranes 
through its actions as a non-ionic detergent, as opposed to protease 
digestion which acts by digesting protein portions of the cell 
8 10 
membrane. ' Enzymatic digestion, while exposing some antigenic 
sites destroys others ; therefore, time, temperature and pH must all be 
carefully controlled to ensure consistent tissue digestion to optimally 
expose the antigenic sites. Such precise control of these variables is 
not critical with the TBS-EDTA-Tween technique. 
The more intense peroxidase labeling of the TBS-EDTA-Tween treated 
sections results from Tween's ability to unmask antigens without 
altering antigenic determinants and lowering surface tension, which 
allows deeper and more uniform penetration of labelling antibodies and 
reagents into the section.The TBS-EDTA-Tween treatment of 
sections decreases non-specific background through better elution of 
unbound reagents and decreased non-specific binding of antibodies 
through hydrophobic interactions with the tissue. 
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The staining characteristics of the protease digested infected tissues 
are compatible with those described by Bryson et al.^'^ Inclusions 
similar to those seen in the protease digested sections were reported with 
the use of fluorescent antibody techniques and were attributed to 
differences in antigenicity of BRSV strains and antisera specificity.^ 
In contrast, our results indicate the difference in staining is the result 
of the technique used since our antiserum and viral strains were 
homologous. Either TBS-EDTA-Tween treatment is not unmasking the antigens 
comprising the inclusions or staining of inclusions is obscured by the 
homogenous cytoplasmic staining. 
The decreased intensity of staining for BRSV antigen in glutaraldehyde 
fixed tissues in comparison with either formalin or paraformaldehyde 
fixation is attributable to the extensive crosslinking and irreversibility 
of glutaraldehyde fixation. 
The TBS-EDTA-Tween technique aids in the diagnosis of BRSV by 
decreasing the non-specific background staining of necrotic and inflamed 
tissue, prominent in many samples received by diagnostic laboratories. 
From the research aspect, protease causes loss of cellular detail while 
the TBS-EDTA-Tween treatment did not cause noticeable tissue damage. This 
is of major importance for identification and examination of infected 
cells. For these reasons we feel that the TBS-EDTA-Tween technique is 
more advantageous than protease digestion for detection of BRSV antigen in 
fixed tissues for diagnostic and research purposes. 
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Figures 1-3.) BRSV infected lung tissue 
Figure 1. a.) BRSV infected lung tissue stained with inununoperoxidase 
for BRSV antigen after TBS-EDTA-Tween treatment. 
Infected cells stain brown. Many contain cytoplasmic 
vacuoles (arrow). XlOO 
b.) Adjacent section to tissue pictured in Figure la stained 
with immunoperoxidase for BRSV antigen after protease 
treatment. Infected cells stain brown, many contain 
intracytoplasmic inclusions (arrow). Non-specific 
background staining is evident in uninfected cells and 
bronchiolar exudate. XlOO 

Figure 2. a.) BRSV infected lung tissue stained with inmunoperoxidase 
for BRSV antigen after TBS-EDTA-Tween treatment. Same 
field as pictured in Figure 1 at a higher 
magnification. Cellular outlines are distinct and 
cytoplasm of infected cells stains uniformly, many 
contain vacuoles (arrow). X250 
b.) Adjacent section to tissue pictured in Figure 2a stained 
with immunoperoxidase for BRSV antigen after protease 
treatment. Cellular outlines are indistinct and 
cytoplasmic staining of infected cells is not uniform. 
Distinct intracytoplasmic inclusions (arrow) are present 
in many infected cells. X250 
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Figure 3. a.) Infected bronchiolar epitlelial cells stained for BRSV 
antigen after TBS-EDTA-Tween treatment. Cilia are 
evident with staining of viral antigen most intense 
along cilia and apical cell membrane of some cells. 
X400 
b.) Adjacent section to tissue pictured in Figure 3a stained 
with immunoperoxidase for BRSV antigen after protease 
treatment. Cilia are not evident. Loss of other 
cellular detail and increased non-specific staining is 
evident. X400 
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ABSTRACT 
We have determined the first cell types to stain for viral antigen 
in lung tissue from sheep infected with bovine respiratory syncytial 
virus (BRSV). Indirect immunoperoxidase, performed on paraffin 
embedded sections, and transmission electron microscopy were used to 
determine the location of BRSV antigen at time intervals between 0.5 
day and 8 days post-inoculation (P.I.). Respiratory syncytial virus 
antigen was detected in alveolar macrophages in tissues collected at 
0.5 day P.I. Our conclusion is that alveolar macrophages are the first 
cell type in which BRSV antigen can be detected in the sheep lung 
following exposure to respiratory syncytial virus but that macrophage 
infection is rare. Antigen was primarily restricted to bronchiolar and 
alveolar epithelium. Bronchiolar epithelium and Type I pneumocytes 
simultaneously stained for BRSV antigen in tissues collected from 1-6 
days P.I. and comprised the majority of infected cells. Lung slices 
inoculated in vitro with respiratory syncytial virus did not stain for 
BRSV antigen. 
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INTRODUCTION 
Respiratory syncytial virus (RSV) is a prevalent respiratory 
O 01 
pathogen in primates and ruminants. ' It is the major cause of 
respiratory disease with subsequent hospitalization of children less 
in 
than 3 years of age. Moreover,bovine RSV (BRSV) is a primary viral 
9  0 *35 
respiratory pathogen in bovine. '' It is common in co-infections 
with other respiratory pathogens such as parainfluenzavirus 3 and 
Pasteurella haemolvtica and is often the sole agent associated with 
acute, fatal interstitial pneumonia and bronchiolitis in yearling 
O Q 
cattle. ' The incidence of RSV infection in cattle is 60-80%, but 
the incidence of disease associated with infection is unknown.^ An 
ovine isolate of RSV has been associated with mild respiratory disease 
in sheep^^ but data regarding incidence of clinical disease is 
lacking. 
Cattle that die from acute respiratory disease caused by BRSV 
infection commonly develop atypical interstitial pneumonia. The lungs 
are diffusely edematous, have widespread emphysema and fail to collapse 
•J 0 
when the thoracic cavity is opened. ' 
Histological changes that characterize atypical interstitial 
pneumonia caused by natural infection with BRSV are severe and diffuse 
necrotizing bronchiolitis and interstitial pneumonia, with alveolar 
edema. Type II epithelial cell hyperplasia, hyaline membranes, 
9  Û interstitial emphysema and syncytial cells. ' Eosinophilic, 
intracytoplasmic, viral inclusion bodies may be present within 
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bronchiolar epithelium or syncytia. Attempts have failed to 
experimentally reproduce atypical interstitial pneumonia with BRSV 
infection in cattle. Indeed, experimental infection with BRSV in 
neonatal calves and lambs results in bronchitis, bronchiolitis and 
interstitial pneumonitis with interstitial lymphocytic infiltrates, 
epithelial necrosis and syncytia, but interstitial emphysema and other 
changes characteristic of atypical interstitial pneumonia are rare or 
7 ^9 
absent. There are no reports of severe lesions in 
yearling cattle or sheep experimentally infected with BRSV. 
Considerations for differences between experimental and field cases 
include; multiple strains of BRSV which vary in virulence,^ 
attenuation of field strains or selection of avirulent strains during 
laboratory virus isolation, viral co-infections in field 
A 28 
cases, ' and immunopathologic components which contribute to severe 
respiratory disease in cattle naturally infected with 
BRSV.3'^5'^^'2^ Data are lacking or inconclusive for any of the 
above considerations. For certain, the difference in lesion 
distribution between natural and experimental infections is indicative 
O 
of different cell types being affected in the two instances. 
A critical event in any infectious disease is the initial site of 
infection. In calves experimentally infected with BRSV, epithelial 
necrosis and viral antigen are detected at all levels of the 
respiratory tract.In contrast, in sheep experimentally infected 
with BRSV, necrosis and antigen are restricted"primarily to bronchiolar 
o on 
and alveolar epithelitjm. » In experimental studies in cattle and 
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sheep, BRSV antigen has been detected in lung tissue from animals 
killed at 2 days post-inoculation (P.I.)•^^Tissues were 
collected from one calf at 1 day P.I. and examined, but no BRSV antigen 
was detected.^ Antigen present in tissues collected at 2 days P.I. 
is presumably the result of 4 or more viral replications. As a 
result, the site of initial infection could not be determined because 
by 2 days P.I. the virus would have spread from the initial infected 
cell population to adjacent non-infected cells. Moreover, in the 
majority of field and experimental cases, antigen location has been 
6 7 51 o o determined using immunofluorescent techniques. These 
techniques are less sensitive than immunoperoxidase techniques^^ and 
greatly compromise histopathological examination of the tissue, so that 
determination of specific cell types infected is difficult. 
Our study had two objectives. First, to determine the initial cell 
types infected in sheep lung after one exposure to virus. Second, to 
examine the progression of infection and lesion development. We used 
99  
an indirect immunoperoxidase technique to detect BRSV antigen in 
tissues that had been flooded with viral inoculum either in vivo or in 
23 
vitro . Flooding the lung with viral inoculum assured us that the 
lung tissue obtained for histological examination had been exposed to 
virus. We determined BRSV antigen presence at the approximate end of 
one viral replication cycle. This protocol allowed us to identify the 
cell types that were first stained for viral antigen after exposure of 
all levels of the respiratory tract to BRSV. Additionally, we 
determined antigen location as the infection progressed. 
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MATERIALS AND METHODS 
In vivo 
Two groups of Border Leicester sheep (10-18 mos.) were used. All 
animals had anti-BRSV titers of <1:8 as determined by indirect 
OA 
hemagglutination. A bovine isolate of RSV, strain 375, inoculum 
was prepared as two batches from primary ovine fetal turbinate 
1 ft 
cells. Treated sheep (n-16) received. BRSV strain 375, ninth and 
tenth passages or BRSV strain 375, twelfth and thirteenth passages. 
Both batches of inoculum had a tissue culture infective dose^Q 
(TCID^q) of 1 X 10®'^/ml. Inoculum for control sheep (n=5) was 
prepared from either noninfected ovine fetal turbinate cells or from 
viral inoculum inactivated by heating to 56°C for 30 minutes. Sheep 
were anesthetized with xylazine, 0.1 mg/kg i.v. and positioned in right 
lateral recumbency. In order to expose the entire respiratory tree the 
right cranial lung lobe was instilled with 75 ml of inoculum using a 
fiberoptic bronchoscope. Additionally, each animal was inoculated 
transtracheally (20 ml) and intranasally (2 ml). 
Two infected animals were killed at each of the following times: 
0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0 and 8.0 days P.I. Three control 
sheep were inoculated with sterile inoculum. Two were killed at 0.5 
days P.I. and one at 3 days P.I. Another two control sheep received 
inactivated inoculum and were killed at 0.5 days P.I. Anti-RSV titers 
were determined on sera collected from each sheep prior to inoculation 
?0 
and at the time of euthanasia. 
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Sheep were euthanatized with Sleepaway (Fort Dodge Labs, Fort 
Dodge, lA) and exsanguinated. Thoracic cavities were opened and 
tissues aseptically collected from the ventral apex of the right 
cranial lobe of the lung for isolation of virus and bacteria. 
Bacterial isolation was performed on blood, MacKoney and Hayflick 
agar. 
After sampling the cut apical surface of the lung was clamped with a 
hemostat. The thoracic viscera was removed from the thorax and the 
right cranial lobe of the lungs was fixed by intratracheal instillation 
of 4% paraformaldehyde in O.IM cacodylate buffer at a pressure of 30 cm 
H2O. Tissues were fixed for 2-6 hours, trimmed, and stored in O.IM 
cacodylate buffer. 
For light microscopic evaluation, the cranial lobe of the right 
lung was divided into quadrants (cranial dorsal, cranial ventral, 
caudal dorsal, caudal ventral). A 1-2 cm block was taken from 
approximately the same area within each quadrant from each animal, with 
the exception of one animal at 0.5 day P.I. in which only the caudal 
quadrants were sampled. Tissues were processed by routine paraffin 
embedding techniques. Nasal turbinates, trachea, right cranial 
bronchial and mediastinal lymph nodes, liver and spleen were also 
collected for histologic evaluation. These tissues were fixed by 
submersion in 4% paraformaldehyde in O.IM cacodylate buffer overnight, 
stored in fixative and processed by routine paraffin techniques. 
For all the tissues collected paraffin sections of 4 urn 
thickness were stained with hematoxylin and eosin for histologic 
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evaluation. For the respiratory tract tissues and lymph nodes, 
0 0  
additional sections were stained for BRSV antigen and Factor 
o 
Vlll-related antigen using an immunoperoxidase ABC procedure. The 
primary antibody against BRSV antigen was rabbit antisera made to the 
whole virus (Dr. C. Kucera, Norden Lab., Inc., Lincoln, NE). The 
primary antibody against Factor VIII related antigen was a rabbit 
antisera obtained commercially (DAKO Corp., Carpinteria, CA). The 
remaining immunoperoxidase reagents were obtained commercially 
(Vectastain ABC Kit, Vector Lab., Burlingame, CA). 
Negative controls for immunoperoxidase procedure consisted of 
substitution of normal rabbit sera for the primary antibody. For BRSV 
specificity, additional negative controls consisted of lung tissue from 
noninfected sheep and lung tissue from sheep infected with either 
parainfluenzavirus 3 or ovine adenovirus. The parainf luenzavirus 3 and 
adenovirus infected tissues were obtained from previous experiments. 
The following categories were created for scoring the number of 
infected cells in histological sections; turbinate epithelium, tracheal 
epithelium, bronchial epithelium, bronchiolar epithelium. Type I 
pneumocytes. Type II pneumocytes, alveolar macrophages, unidentifiable 
cells. When Type I pneumocytes on adjacent sides of septa stained for 
viral antigen, it was presumed to be the same cell and thus scored as 
1, Each section was examined in its entirety. 
For electron microscopic evaluation, the cranial lobe of the right 
lung was divided into cranial and caudal portions. From each portion, 
6 or more samples were taken from tissue adjacent to areas samples for 
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light microscopy. The tissues were stored in O.IM cacodylate buffer, 
post-fixed in osmium tetroxide, cleared in propylene dioxide, 
dehydrated through ethanol and embedded in epoxy resin in BEEM capsules 
(Electron Microscopic Services, Inc., Fort Washington, PA). One fim 
thick sections were cut and stained with toluidine blue. Thin sections 
were cut from selected blocks with a LKB ultramicrotome (LKB 
Instruments, Inc., Schaumburg, IL) and stained with lead citrate and 
uranyl acetate^^ for subsequent examination on a Phillips 410 
electron microscope (Phillips Corp., New York, NY). 
In vitro 
Noninfected sheep were euthanatized with Sleepaway, (Fort Dodge 
Labs, Fort Dodge, lA) and exsanguinated. Lungs were removed 
aseptically and lung slices of 300 /im thickness were obtained 
utilizing a Vibratome-1000^ (Electron Microscopy Services, Redding, 
CA) . Slices were flooded with BRSV inoculum at a titer of 
approximately 1 x lO^TCID^g. To assess the value of lung slice 
organ cultures in studying viral respiratory pathogens, additional 
slices were inoculated with either ovine adenovirus, serotype 6, strain 
151 at a titer of 1x10^*^^ TCID^q or parainfluenzavirus-3 at a 
titer of lxlO^'^5 TCID^q. Inoculum was left in contact with the 
slices for 1 hour. The slices were then rinsed with fresh minimal 
essential media supplemented with 10% fetal calf sera, 0.24 mg/ml of 
glutamine, and 0.05 mg/ml of gentomycin and slices were incubated at 
37°C with 5% CO2 in room air.Noninoculated control slices 
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were incubated concurrently. Control and infected tissue samples were 
taken at each of the following time periods: 0, 0.5, 1.0, 1.5, 2 and 3 
days P.I. Slices were rinsed in phosphate buffered saline, fixed by 
submersion in 4% paraformaldehyde in O.IM cacodylate buffer and 
processed for light microscopic evaluation. Ovine adenovirus and BRSV 
antigen detection was carried out using the indirect immunoperoxidase 
technique previously described. Parainfluenzavirus-3 antigen detection 
was carried out using direct immunoperoxidase with protease digestion 
to unmask viral antigen. Rabbit anti-ovine adenovirus and 
biotinylated goat anti-human parainfluenzavirus-3 (Virostat, Portland, 
ME) antibodies were used for the primary antibodies against the 
respective viruses. Negative controls consisted of noninfected tissues 
and substitution of normal sera for primary antibody. Positive controls 
consisted of lung tissues from sheep which had been experimentally 
infected with the respective viruses. 
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RESULTS 
In vivo 
Clinical signs, serology, virus isolation 
Clinical signs of respiratory disease were not observed until 6 and 
7 days P.I. when two sheep presented with mild dyspnea. Rectal 
temperature was elevated (41°C) in one sheep at P.I. day 8. Starting 
in sheep killed at 4 days P.I. serum anti-BRSV titers were increased 
from preinoculation titers (Table 1). None of the control animals 
developed elevated anti-BRSV titers or had clinical signs. Respiratory 
syncytial virus was isolated from lung tissue of all sheep killed 
through 4 days P.I. and from one sheep killed at 6 days P.I. Virus was 
not isolated from lung tissues of BRSV inoculated sheep that were 
killed at 8 days P.I. Virus was not isolated from any control sheep. 
Bacteria, including mycoplasma, were not isolated from lung tissue of 
any of the sheep in this experiment. 
Macroscopic lesions 
There were locally extensive raised areas on the lung surface of 
one sheep killed at each 0.5 days P.I. and one killed at 1.0 day P.I. 
One of the sheep killed at 4 days P.I. had a minimally accentuated 
lobular pattern and the second sheep had a moderately enlarged cranial 
bronchial lymph node. One of the sheep killed at 6 days P.I. had a 
minimally accentuated lobular pattern. The lungs of the other sheep 
killed at 6 days P.I. failed to collapse and lung distention during 
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instillation of fixative was not uniform. Mediastinal lymph nodes of 
both sheep killed at 6 days P.I. were reddened. One sheep killed at 8 
days P.I. had a focal area of pulmonary hemorrhage (<1 cm) and numerous 
raised lobules. The other sheep killed at 8 days P.I. also had 
multiple raised areas and the entire lung failed to completely 
collapse. Two control sheep, inoculated with sterile inoculum had 
focal reddened areas of atelectasis at 0.5 days F.I. 
Microscopic lesions 
Sheep killed at 0.5 day P.I. had minimal multifocal bronchiolitis 
and pneumonia with exudates of mixed populations of neutrophils, 
macrophages and lymphocytes and occasional areas of thickened alveolar 
septae (Figure 1). Tissues from sheep killed at 1.0 and 1.5 days P.I. 
had minimal to moderate multifocal bronchiolitis and pneumonia with 
exudate composed of neutrophils, macrophages and lymphocytes and 
sloughed epithelium in alveolar spaces and terminal bronchioles. 
Interstitial changes consisted of perivascular and peribronchiolar 
lymphocytic infiltrates and multifocal moderate distention of alveolar 
septae (Figure 2). At 2 days P.I. there was minimal multifocal 
bronchiolitis and interstitial pneumonitis with perivascular and 
peribronchiolar lymphocytic infiltrates. Some terminal bronchioles 
were partially occluded with mixtures of mucus and cellular exudate. 
There was focal necrosis of alveolar epithelium characterized by loss 
of lining epithelium, fibrin accumulation within alveolar septae and 
fibrin and RBCs in alveolar spaces pneumonia (Figure 3). At 3 days 
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P.I. there were multifocal mild peribronchiolar and moderate 
perivascular lymphocytic infiltrates, slight Type II cell hyperplasia, 
interstitial edema, and alveolar exudates comprised primarily of 
macrophages and lymphocytes (Figure 4). Histological changes at 4, 6 
and 8 days P.I. were similar to the changes in lung tissue of sheep 
killed at 3 days P.I., with extension of the perivascular and 
peribronchiolar lymphocytic infiltrates into distended alveolar septa 
(Figure 5). Multifocally, terminal bronchioles lined by necrotic 
epithelium characterized by pyknotic nuclei and vacuolated cytoplasm. 
There were also areas of attenuated bronchiolar epithelium at the 
latter time periods. Exudates of macrophages, lymphocytes and 
neutrophils were in bronchioles and alveoli. Alveolar exudates were 
composed primarily of lymphocytes and macrophages. 
In tissues other than lung the following was seen. Starting at 1.0 
day P.I., cranial bronchial and mediastinal lymph nodes were minimally 
edematous with prominent lymphoid nodules, and increased numbers of 
macrophages and lymphocytes were present within medullary sinuses. 
Turbinates and trachea of some animals had very minimal submucosal 
lymphocytic infiltrates. One animal had focal epithelial erosion in 
the trachea. There were no significant changes in any other tissues 
from infected animals. 
Histological changes in control animals at 0.5 day P.I. included 
minimal, bronchiolitis and pneumonia with exudate consisting primarily 
of neutrophils with fewer macrophages and lymphocytes. There were also 
minimal multifocal perivascular lymphocytic infiltrates and very 
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minimal Type II cell hypertrophy. Histological changes at 3 days P.I. 
included scattered minimal perivascular and peribronchiolar lymphocytic 
infiltrates. 
TTTiTTninnhistochemistrv 
At 0.5 days P.I., a few macrophages were the only cells positive 
for BRSV antigen (Table 2). At 1 day P.I. there was viral antigen in 
Type I pneumocytes, bronchiolar epithelium, alveolar macrophages and a 
single bronchial epithelial cell. At 1.5 and 2 days P.I. antigen was 
present in Type I pneumocytes, macrophages and bronchiolar epithelium. 
At the remaining time periods, in addition to the above cell types, 
antigen was detected in Type II pneumocytes (Table 2). The staining 
pattern up through 3 days P.I. was one of a few scattered infected 
cells per high power field and the foci of infection were often not 
associated with inflammatory cells (Figures 6, 7, 8 & 9). At 6 days 
P.I. there were locally extensive areas of bronchiolar and alveolar 
epithelium which stained for antigen (Figures 10 & 11). Antigen was 
often concentrated at the apical surface of ciliated and non-ciliated 
epithelial cells of bronchioles. At 8 days P.I., all tissues examined 
were negative for antigen. Some of the cells which stained for BRSV 
antigen resembled endothelial cells. However, the cells that appeared 
to be endothelium and stained for viral antigen lacked staining for 
Factor VIII antigen in adjacent serial sections. Occasionally, 
non-specific staining was localized along the area of the basement 
membranes of bronchiolar and alveolar epithelium. There was also 
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staining of some debris in alveolar spaces and bronchiolar lumens. 
There was no staining for viral antigen in any of the bronchial or 
mediastinal lymph nodes. 
Electron microscopy 
Virions were identified ultrastructurally in association with 
bronchiolar and alveolar epithelium (Figures 12 & 13). Despite several 
trials of many different protocols including etching of sections, 
pre-embedding labeling of tissues, and resin removal from sections, 
viral antigen was not detected at the electron microscopic level using 
immunocytochemical techniques. 
In vitro 
There was staining for parainfluenzavirus-3 antigen in macrophages 
at 0.5 days P.I. At 1 day P.I. there was staining for 
parainfluenzavirus-3 antigen in bronchiolar epithelium. At 3 days P.I. 
bronchiolar epithelium in every airway and occasionally alveolar 
epithelium of inoculated lung slices stained for parainfluenzavirus-3 
antigen. There was no staining of BRSV or ovine adenovirus antigen in 
any of the lung slices inoculated in vitro. 
64 
DISCUSSION 
The paucity of BRSV positive macrophages, in comparison to other 
infected cell types, is consistent with sheep alveolar macrophages not 
being very susceptible to BRSV infection in vitro. The lack of 
positive staining in animals given inactivated inoculum indicates that 
macrophage staining most likely represents infection and not staining 
of phagocytized viral antigen. Alveolar macrophages are a heterogenous 
population. In vitro, human monocytes are more supportive of RSV 
replication as they age and become more macrophage-like.The 
alveolar macrophages staining for BRSV in these sheep may represent a 
sub-population that is permissive in regards to BRSV replication. 
Alveolar macrophages were the first cells in which BRSV antigen was 
detected. For alveolar macrophages to attain detectable levels of 
viral antigen before any other cells in the lung indicates that either 
viral replication is more rapid in alveolar macrophages than in 
epithelium or that the rate of exposure to the virus is higher for 
alveolar macrophages than for epithelium. There are no reports 
comparing the replication of BRSV in macrophages to that in 
epithelium. The exposure rate of alveolar macrophages to BRSV would be 
expected to be higher than the exposure rate of respiratory epithelium 
because macrophages are not provided protection by mucus or alveolar 
lining material. 
Our results are consistent with the previous studies in sheep, in 
which BRSV infection produced a bronchiolitis, interstitial pneumonitis 
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and pneumonia. Viral antigen was detected at 2 days P.I. primarily in 
Q OO 
bronchiolar and alveolar epithelium. ' In experimentally infected 
calves BRSV antigen was detected at 2 days P.I. at all levels of the 
respiratory tract but was most prevalent in the bronchi.In 
our study, the staining of antigen in both bronchiolar and alveolar 
epithelium at 1 day P.I. suggests that there is not a preferential 
primary infection of one of these epithelial cell types. Viral antigen 
positive cells that histologically resembled endothelium but failed to 
stain for Factor VIII-related antigen in serial sections probably 
represent Type I pneumocytes lining narrow alveolar spaces. The 
paucity of infected cells and inability to label viral antigen at the 
electron microscopic level precluded us from carrying out morphometric 
analysis on infected cell types. However, the light microscopic data 
indicate that the greatest proportion of infected cells are Type I 
pneumocytes. Type I pneumocytes cover the majority of lung surface 
area and so have a greater risk of exposure in comparison to other cell 
types in the lung. The number of each of the different cell types 
infected could reflect the incidence of exposure and not a preference 
of infection. 
The tremendous capability of the lung to clear itself of airborne 
pathogens was indicated by the paucity of BRSV-infected cells in these 
sheep which had been infected by flooding an entire lung lobe with 
viral inoculum. The mucociliary apparatus comprises a large portion of 
the lungs' defense capabilities.^ Mucus and alveolar lining 
material prevent airborne pathogens from gaining access to the 
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underlying epithelium.^® However, the protection is not uniform 
throughout the respiratory tract. The mucous layer varies in 
composition along the respiratory tract and may not be 
continuous.In addition, mucus and alveolar lining material are 
cleared more slowly from the terminal airways and alveoli than from the 
bronchi and trachea. The slower clearance favors the establishment of 
many respiratory infections in the distal respiratory tract. 
Bovine respiratory syncytial virus is able to infect a number of 
different cell types in vitro and in our experiment was present in 
bronchial epithelium in one sheep. This suggests that the epithelium 
of the upper respiratory tract would support viral replication if 
exposed. The restriction of BRSV infection to bronchioles and alveoli 
in this study is indicative of the areas of the respiratory tract that 
are least protected. 
The failure of antigen detection and virus isolation at 8 days P.I. 
coincided with a marked seroconversion, as such virus may have been 
cleared or masked by immunoglobulins. This elimination of virus 
plus minimal to moderate pulmonary lesions is evidence of protection 
provided by the immune response in these sheep. 
The paucity of BRSV infected cells in lung tissues from inoculated 
animals was unexpected. This could explain the lack of infection in 
the lung slices after in vitro inoculation. A low incidence of 
infection combined with the limited number of cells in a lung slice 
might not allow establishment of infection. The validity of using lung 
slices for studying some viral infections was evidenced by the 
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infection of slices by parainfluenzavirus-3. The comparable titers of 
the 3 viruses used in this study indicates that parainfluenzavirus-3 is 
the most capable of establishing pulmonary infections in our model. 
The use of our sheep model allowed us to determine the site of 
infection initiation and progression. All previous experimentation 
with BRSV in calves and sheep has used either aerosolization, or 
fi 7 transtracheal inoculation. ' These forms of inoculation give a 
very limited exposure of the lung surface area to the virus. To 
determine the initial cells infected by BRSV we had to ensure that the 
tissues collected at 0.5 and 1.0 day P.I. had been exposed to the 
virus. By flooding a lobe of the lung we ensured exposure of the 
collected lung tissue and we were able to detect BRSV-infected cells 
before any secondary foci of viral infections could be established. 
Using our model, comparison of antigen staining and lesions of BRSV 
infections in cattle and sheep may help explain the pathogenesis of 
severe respiratory disease caused by BRSV infection in cattle. In 
addition, attempts can be made to enhance the lesions caused by BRSV 
infection of sheep; for example, by inoculating sheep of different ages 
or serostatus with respect to BRSV. 
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Table 1. Serology and virus isolation at various times post-inoculation for BRSV-infected 
and control sheep 
Time Pre- inoculation* Post-inoculation 
Sheep post-Inoculation antl-BRSV antl-BRSV BRSV 
No. days IHA titer IHA titer Isolation 
Infected Sheet) 
2829 0.5 1:4 1:4 + 
2878 1:4 1:4 + 
2802 1.0 1:2 1:4 + 
2796 1:4 1:4 + 
2814 1.5 1:4 1:4 + 
2841 1:4 1:4 + 
2801 2.0 1:4 1:4 + 
2870 1:4 1:4 + 
2799 3.0 1:4 1:4 + 
2805 1:4 1:4 + 
2825 4.0 1:8 1:512 + 
2877 1:4 1:16 + 
2942 6.0 1:4 1:4 
2951 1:4 1:8 + 
2962 8.0 1:4 1:1024 
2978 1:4 1:1024 -
Control Sheep 
Sterile inoculum 
2828 0.5 
2824 0.5 
2830 3.0 
Inactivated inoculum 
2815 0.5 
2865 0.5 
^Pre-inoculation sera was collected on the day of inoculation. 
^Post-inoculation sera was collected at the time of euthanasia. 
'^Post-inoculation blood samples were not taken. 
+ Virus was isolated from lung tissue. 
- No virus was Isolated from lung tissue. 
1:2 
1:4 
1:4 
1:4 
1:8 
1:2 
1:4 
1:4 
_c 
c 
Table 2. Cell types staining for BRSV antigen at various times post-inoculation in 
infected sheep* 
Sheep P.I.b Bronchial Bronchiolar Type I Type II Alveolar 
No. days epithelium epithelium pneumocytes pneumocytes macrophages Other 
2829 0.5 0 0 0 0 1 0 
2878 0.5 0 0 0 0 2 0 
2802 1.0 1 2 12 0 6 2 
2796 1.0 0 4 0 0 5 1 
2814 1.5 0 12 11 0 6 1 
2841 1.5 0 6 18 0 1 9 
2801 2.0 0 5 14 0 2 3 
2870 2.0 0 15 17 0 9 10 
2799 3.0 0 20 141 6 1 28 
2805 3.0 0 9 157 2 0 7 
2825 4.0 0 16 21 1 3 4 
2877 4.0 0 345 446 29 1 56 
2942 6.0 0 416 146 2 3 86 
2951 6.0 0 7 43 3 0 32 
2962 8.0 0 0 0 0 0 0 
2978 8.0 0 0 0 0 0 0 
^Turbinate and tracheal epithelium had no staining. 
^Days post-inoculation. 
Figures 1-5. BRSV infected lung tissue. Hematoxylin & eosin. 
Figure 1. Lung, sheep #2878, 0.5 day P.I. Mixed inflammatory cells 
within bronchioles and alveolar spaces with scattered areas 
of thickened alveolar septae. Hematoxylin and eosin. XlOO 
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Figure 2a. Lung, sheep #2814, 1.5 day P.I. Mixed inflammatory-
exudate within, bronchi, terminal bronchioles and 
alveoli. Multi-focal paribronchiolar and perivascular 
lymphocytic infiltrates. Hematoxylin and eosin. X40 
Figure 2b. Lung, sheep #2841, 1.5 day P.I. Peribronchiolar and 
perivascular lymphocytic infiltrate with sloughed 
bronchiolar epithelium (arrow) and interstitial edema. 
Hematoxylin and eosin. X195 
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Figure 3. Lung, sheep #2870, 2 days P.I. Fibrin (arrow) and 
RBCs (arrowhead) in alveolar spaces with low 
numbers of mixed inflammatory cells. Hematoxylin and 
eosin. X262 
82 
Figure 4a. Lung, sheep #2805, 3 days P.I. Perivascular 
lymphocytic infiltrates with perivascular edema (arrow). 
Hematoxylin and eosin. X50 
Figure 4b. Lung, sheep #2799, 3 days P.I. Alveolar septal distention 
with interstitial infiltrates of macrophages and lympho­
cytes. Minimal Type II pneumocyte hyperplasia. Alveolar 
exudate of macrophages, lymphocytes and lesser numbers of 
neutrophils. Hematoxylin and eosin. X195 

Figure 5. Lung, sheep #2942, 6 days P.I. Inadequately instilled 
area as result of bronchiolar plugs formed from necrotic 
cell debris and inflammatory cells (arrow). Peribronchio­
lar lymphocytic infiltrates extend into the alveolar septa. 
Some alveolar spaces are filled with macrophages, lympho­
cytes and lesser numbers of neutrophils. Type II pneumo-
cytes are hyperplastic (arrowheads, closed), bronciolar 
epithelium is irregular and vacuolated (arrowhead, open). 
Hematoxylin and eosin. X156 
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Figures 6-12. Lung tissue stained with immunoperoxidase for BRSV 
antigen. Infected cells stain brown, Mayer's 
hematoxylin counterstain. 
Figure 6. Lung, sheep #2801, 2 days P.I. BRSV infected Type I 
pneumocyte outlines the corner of an alveolus. X590 
Figure 7. Lung, sheep #2799, 3 days P.I. BRSV infected Type I and 
Type II pneumocytes. X200 
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Figure 8. Lung, sheep #2799, 3 days P.I. BRSV infected bronciolar 
cells, intact (arrow) and partially sloughed (arrowhead) 
with associated macrophage. Note apical portion of cells 
staining for antigen. X500 
Figure 9. Lung, sheep #2799, 3 days P.I. Necrotic Type I pneumocyte 
(arrow) and unidentifiable cell (arrowhead) stain diffusely 
for BRSV antigen. X630 
90 
Figure 10. Limg, sheep #2877, 4 days P.I. Locally extensive area 
of BRSV infected Type I, Type II, and bronchiolar 
epithelium. X128 
Figure 11. Lung, sheep #2942, 6 days P.I. Infected epithelium lines 
portions of a bronchiole. X200 
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Figures 12 & 13. BRSV infected lung tissue. 
Figure 12a. Lung, sheep #2801, 2 days P.I. BRSV 
particles associated with ciliated bronchiolar 
epithelium. Both cells are partially sloughed. 
Bar - 1 fim 
Figure 12b. Lung, sheep #2801, 2 days P.I. Same field as Figure 12a, 
higher magnification of viral particles (arrows). Bar = 1 
fim 
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Figure 13a. Lung, sheep #2841, 1.5 days P.I. BRSV particles and buds 
in association with an unidentified alveolar 
epithelial cell. Bar - 1 pm 
Figure 13b. Lung, sheep #2841, 1.5 days P.I. Same field as Figure 
13a, higher magnification of infected cell and associated 
viral particles (arrow). Bar - 0.5 fim 
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GENERAL DISCUSSION AND SUMMARY 
There are several reports of bronchitis, interstitial pneumonitis 
and pneumonia caused by experimental BRSV infection in calves and 
lambs.All but one of the reported studies involve 
neonatal, colostrum deprived or gnotobiotic animals. Natural 
infection of calves with BRSV can cause atypical interstitial 
5 99 pneumonia. ' This cannot be reproduced experimentally. 
Establishment of infection is a critical step in any infectious 
process. Bovine respiratory syncytial virus antigen has been detected 
at 2 days P.I. in the lung tissue of experimentally infected calves and 
lambs.Tissues collected from calves at 1 day P.I. were 
examined but no viral antigen was detected.Within a 2-day time 
period BRSV could have replicated and spread to establish secondary 
foci of infection. 
The goals of this project were to determine the cell type(s) in the 
lung that first stained for BRSV antigen after exposure to BRSV and to 
follow progression of the infection. To assist in obtaining these 
goals the following techniques were developed; a lung organ culture 
technique that allowed viable lung tissue to be maintained in vitro for 
4 days and an immunoperoxidase staining technique that allowed 
detection of BRSV antigen in sheep lung tissues that had been processed 
by routine paraffin techniques. Bovine respiratory syncytial virus 
infected cells were identified in lung tissue from sheep which 
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had been inoculated with BRSV by flooding the right cranial lobe of the 
lung with virus and from lung slice organ cultures which had been 
inoculated with BRSV in vitro. These inoculation techniques were used 
to optimize the possibility that the sampled lung tissue would contain 
infected cells and to infect large numbers of cells so morphometric 
analysis could be performed to determine if a cell type was 
preferentially infected. We were not attempting to produce severe 
respiratory disease with BRSV infection in lambs. 
We chose to use conventionally reared yearling lambs because RSV is 
a natural respiratory pathogen in sheep and we want to pursue using 
BRSV infection in lambs as a model to study RSV infection in cattle and 
humans. 
In the first portion of this study, an immunoperoxidase staining 
technique was developed to detect BRSV antigen in fixed, paraffin 
embedded tissues. Respiratory syncytial virus antigen is masked by 
routine fixation and processing procedures. Previous studies of calves 
and lambs experimentally infected with BRSV have detected viral antigen 
u s i n g  i m m u n o f l u o r e s c e n c e  o n  f r o z e n  s e c t i o n s ^ ^ ' o r  
immunoperoxidase on fixed tissue sections after enzymatic 
digestion. Both of these techniques sacrifice structural integrity 
for antigen detection. In our immunoperoxidase technique, a detergent 
was used to unmask BRSV antigen in fixed tissue. This allowed 
detection of BRSV antigen without sacrifice of structural integrity and 
in addition decreased non-specific background staining in comparison to 
other techniques. 
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In the second portion of this project, the specific cell types 
which stained for BRSV antigen was determined for lung tissue from 
infected sheep and for lung tissue infected in vitro. The first cells 
to stain for BRSV antigen were alveolar macrophages in tissues from 
sheep killed at 0.5 day P.I. The majority of staining for BRSV 
antigen, present from 1-6 days P.I., was within bronchiolar epithelium 
and Type I pneumocytes. Type II pneumocytes stained for BRSV antigen 
from 3-6 days P.I. With the exception of one bronchial epithelial cell 
there was no staining for viral antigen above the level of the 
bronchioles. Attempts failed to stain BRSV antigen with immunogold 
techniques. Virions were identified ultrastructurally in association 
with bronchiolar and alveolar epithelium. The lung organ culture 
technique allowed us to inoculate lung tissue with virus, in vitro and 
determine, using immunoperoxidase, the infected cell types. Lung organ 
cultures were shown to be useful for evaluating parainfluenzavirus-3 
infection but not for BRSV or an ovine adenovirus infection. 
Parainfluenzavirus-3 readily infected lung slices in vitro. However, 
no BRSV or ovine adenovirus antigen was detected by 
immunohistochemistry in any of the lung slices inoculated in vitro. 
The paucity of BRSV-infected cells and failure to detect viral 
antigen at the ultrastructural level with immuno cyto chemical techniques 
precluded morphometric analysis of infected cell types. The high 
numbers of infected bronchiolar epithelium and Type I pneumocytes may 
reflect incidence of exposure to BRSV and not a preferential infection 
of these two cell types. 
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The failure of BRSV to establish extensive infection in these sheep 
attests to the tremendous clearance capabilities of the lung. The 
moderate lesions produced by BRSV infection in lambs is consistent with 
05 QQ 
previous reports.' There are no reports of experimental BRSV 
infection in yearling cattle. 
Sheep infected experimentally with BRSV can be used as a model to 
study severe respiratory disease caused by BRSV infection in cattle. 
Determining the pathogenesis of severe respiratory disease caused by 
BRSV infection will help minimize RSV's contribution to respiratory 
disease and provide knowledge of inflammatory processes in the lung 
which may apply to other acute respiratory disease processes. 
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Appendix A: 
Use of the Vibratome® for producing uniform slices for 
lung organ culture 
Adult BALB/C mice were killed by cervical dislocation and the 
thoracic cavity opened aseptically. Lungs and trachea were dissected 
free from surrounding tissues, removed from the thoracic cavity and 
kept moist with O.OIM phosphate buffered saline (PBS), pH 7.6, at 
37°C. A mixture of 2% agarose (SeaKemp ME, FMC Bio Products, 
Rockland, ME) in minimal essential media (MEM) was prepared at 56°C. 
The mixture was supplemented with 10% fetal calf sera, 0.05 mg/ml 
Gentocin (Schering Corp., Kenilworth, NJ) and 0.24 mg/ml glutamine 
(supplemented MEM). This mixture of agarose and MEM was cooled to 
37-40°C and transferred to a 5 ml syringe which was connected to the 
mouse trachea via an adapter. The lungs were gently instilled with the 
liquid agarose-MEM until they were uniformly distended. A second set 
of lungs, inflated to a pressure of 20 cm H2O, was used as a guide 
to avoid overinflation. After instillation, the trachea was clamped 
and the lungs were placed in a sealed plastic bag and cooled at 4°C 
for 1/2 hour which allowed che gel to solidify. The lungs were then 
trimmed into 0.5 cm cubes and 300 fim thick sections were cut at 
4°C on a Vibratome (E.M. Supply Center, Redding, CA). The slices 
were stored at 4°C for less than 1.5 hour in supplemented MEM, 
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supplemented as described above, and then spread onto the surface of 
0.2% agarose in supplemented MEM, which was contained in 24 well 
microtiter plates. Each well contained 1 ml of 0.2% agarose-media 
mixture. This concentration of agarose provided adequate support to 
maintain the section at the air-liquid interface. The tissues were 
incubated in a humidified incubator at 37°C with 5% CO2 in room 
air. 
Incubated tissues were harvested daily for 5 days. After rinsing 
with PBS, tissues were fixed in 10% neutral buffered formalin for 
histological evaluation or in 2.5% glutaraldehyde in O.OIM cacodylate 
buffer at 4°C for ultrastructural evaluation. The only tissues 
examined with electron microscopy were those harvested at 3 days 
incubation. 
Microscopic examination of the tissue after 0 to 4 days of 
incubation revealed that alveolar septa and perivascular spaces were 
diffusely distended and occasionally alveolar septa were fractured. 
Lymphocytes were present within the interstitium in low numbers. 
Through 4 days incubation the bronchioles were lined by ciliated 
cuboidal epithelium with occasional areas of attenuated epithelium. 
(Figure 1) At 5 days incubation there was extensive areas of necrotic 
bronchiolar and alveolar epithelium with pyknotic nuclei and granular 
cytoplasm. Many bronchioles were devoid of epithelium. 
Use of the Vibratome® allows slices of uniform thickness (300 
/im) to be obtained and maintained for 4 days in vitro without 
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histological evidence of degeneration. The slices are of adequate size 
to allow processing and subsequent histological examination of multiple 
airways and lung parenchyma within the same section. This lung organ 
culture technique allows the study of acute processes in intact lung 
tissue under very well defined in vitro conditions. 
Figure 1. Lung tissue after 4 days incubation. Bronchiolar and 
alveolar epithelium show no histological signs of 
deterioration and cilia are evident (arrow). X250 
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Appendix B: 
Protocols used in attempts to detect BRSV antigen at 
the electron microscopic level 
Reprocessing of histological sections for electron microscopic 
examination. 
a) A histological section is stained for viral antigen using an 
immunoperoxidase technique 
b) Mark on bottom of glass slide an area of tissue section that is 
positive for viral antigen. 
c) Remove coverslip by soaking in xylene, 60°C for 20 minutes. 
d) Trim away excess tissue, do not allow section to dry. 
e) Clear and infiltrate by placing slide in Koplin jars, 
i) xylene, 5 minutes. 
ii) 50% propylene oxide in xylene, 5 minutes. 
iii) propylene oxide, 5 minutes. 
f) Cover tissue with 25% resin/75% propylene oxide mixture, let 
stand for 5 minutes, do not let tissue dry prior to 
infiltration. 
g) Incubate for 10 minutes at 60°C . 
h) Place inverted BEEM capsule (Electron Microscopic Services, 
Fort Washington, PA.) nearly full of resin over tissue. 
i) Incubate in oven for 60-90 minutes at 95-100°C. . 
j) Remove from oven and pop off inverted BEEM capsule containing 
tissue before slide cools. 
k) Section and stain for transmission electron microscopy. 
Results: Lack of adequate tissue preservation or extensive tissue 
damage incurred during reprocessing prevented any 
assessment of tissue ultrastructure. 
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II. Bovine respiratory syncytial virus antigen detection with 
immunogold labeling in epoxy embedded ovine fetal turbinate 
cells. 
1.) Direct labeling technique. 
a) Respiratory syncytial virus infected cells were suspended 
by trypsinization, formalin fixed and embedded in 2% 
agarose. 
b) Tissue was routinely processed, infiltrated and embedded in 
epoxy resin. 
c) Sections of 70-90 nm thickness on nickel coated grids were 
rehydrated for 10 minutes with distilled water at room 
temperature. 
d) Etched by incubating^ with saturated sodium metaperiodate 
for 5 to 10 minutes at room temperature. 
e) Rinsed 3 times for 5 minutes each with filtered distilled 
water at room temperature. 
f) Antigen was unmasked by incubating with filtered 
Tris-EDTA-Tween buffer for 10 minutes at room 
temperature. 
g) Blocked with normal goat serum for 10 minutes at 37°C. 
h) Primary antibody (5 nm gold labeled anti-RSV monoclonal 
antibody) was applied and incubated overnight at 4°C. 
i) Jet washed with 20 ml of filtered Tris-EDTA-Tween buffer. 
j) Counterstained with uranyl acetate and lead citrate. 
Negative controls consisted of substitution of normal rabbit sera 
for primary antibody. 
Results: No gold was present on sections. 
^ All incubations and rinses were carried out by floating grids, 
section side down, on a drop of reagent. 
^ 0.05M Tris buffered saline + ImM EDTA + 0.05% Tween 20. 
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2.) Indirect labeling technique. 
a) Respiratory syncytial virus infected cells were suspended 
by trypsinization, formalin fixed, and embedded in 2% 
agarose. 
b) Tissue was routinely processed, infiltrated, and embedded 
in epoxy resin. 
c) Sections of 70-90 nm thickness on nickel coated grids were 
rehydrated for 10 minutes with distilled water at room 
temperature. 
d) Etched by incubating with saturated sodium metaperiodate 
for 5 to 10 minutes at room temperature. 
e) Rinsed 3 times for 5 minutes each with filtered distilled 
water at room temperature. 
f) Rinsed for 5 minutes with filtered TBS . 
g) Antigen was unmasked by incubating with Tris-EDTA-Tween + 
1% BSA buffer for 10 minutes at room temperature. 
h) Block by flooding with undiluted sera from the species in 
which the secondary antibody was prepared (Normal goat 
sera) 
i) Excess serum was blotted off. 
j) Primary antibody (rabbit anti-RSV antibody) 
diluted in TBS was applied and incubated overnight at 
4°C. 
k) Jet washed with 20 ml of Tris-EDTA-Tween buffer. 
1) Secondary antibody (15 nm goat labeled anti-rabbit 
antibody) diluted in TBS^ was applied and incubated for 1 
hour at 37°C. 
m) Jet washed with 20 ml of filtered TBS, 20 dips in 5 changes 
of filtered TBS then rinsed 3 times for 5 minutes each with 
filtered TBS at room temperature. 
n) Jet washed with water. 
o) Counterstained with uranyl acetate and lead citrate. 
Negative controls consisted of substitution of normal rabbit 
sera for primary antibody. 
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Results: Specific labeling of antigen was not present. Gold 
particles were present over cellular and acellular 
portions of the sections. There was no increased 
concentration of gold particles on viral structures. 
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The lack of any increased concentration of gold particles on 
virions in the epon embedded sections suggested antigenic sites were 
unavailable either because of destruction during processing and etching 
or because of resin interference with antibody penetration. Epon resin 
is poorly penetrated by antibodies. The decision was made to try a 
hydrophobic resin (LR White) which allows better penetration of 
antibodies, thereby increasing antigen accessibility. 
Immunogold with silver enhancement was chosen for a detection 
system because it would allow antigen detection at both the light and 
electron microscopic levels. 
III. Immunogold-silver enhancement for detection of RSV antigen in 
paraformaldehyde fixed tissues embedded in LR White resin or 
paraffin . 
a) Tissues were processed, infiltrated and embedded in LR 
White^ using thermal polymerization. 
b) 1 ^ m LR White sections were cut on a glass knife and 
floated onto acid cleaned slides using a drop of water or 
acetone. Slides were heated on a hot plate (35-40°C) 
until the section was dry. 
For a positive control paraffin embedded lung tissue sections 
containing foci known positive for viral antigen were run 
concurrently with LR White embedded tissue sections 
c) Paraffin sections were deparaffinized with xylene and 
rehydrated through graded alcohols. LR White sections were 
rehydrated with distilled water 
d) Antigen was unmasked by incubating in Tris-EDTA-Tween buffer 
for 10 minutes at room temperature. 
e) Blocked by flooding with normal goat sera in TBS/PBS^ for 
20 minutes at room temperature. 
f) Excess goat serum blotted off. 
g) Primary antibody (rabbit anti-RSV) applied and incubated 
overnight at 
^ Polysciences Inc., Warrington, PA. 
^ One part 0.05M Tris buffered saline + 10 parts O.OIM phosphate 
buffered saline. 
^ All incubations were carried out in a humidified chamber. 
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h) Rinsed by flushing 3 times with Tris-EDTA-Tween buffer. 
i) Secondary antibody (15 nm gold labeled goat anti-rabbit) 
applied diluted in Tris buffered saline + 1% BSA and 
incubated for 90 minutes at room temperature. 
j) Flushed 3 times with Tris-EDTA-Tween buffer. 
k) Silver enhancement performed (Intense M kit, Jansen Biotech 
N.V., Olen, Belgium), incubated until desired intensity 
was achieved. 
1) Washed in tap water. 
m) Counterstained for 1 minute with toluidine blue. 
Results: There was no positive staining on paraffin sections in 
areas of known viral antigen presence. 
Numerous LR White sections were lost during rinse 
prior counterstaining. Most likely resulting from the 
hydrophilic properties of LR White preventing adequate 
adherence of the sections to the slides. 
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The failure of attempts using immunogold silver enhancement 
to label known positive paraffin sections indicated that at the light 
microscopic level it was not as sensitive as the immunoperoxidase 
technique. It was decided to try the immunoperoxidase technique on LR 
White and epoxy embedded tissue sections. 
IV. Respiratory syncytial virus antigen detection in LR White embedded 
lung tissue sections on acid cleaned slides using immunoperoxidase 
immunohistochemistry. 
Lung tissue from a sheep infected with BRSV was processed, 
infiltrated and embedded in LR White using thermal polymerization 
1 fm LR White embedded tissue sections were floated onto acid 
cleaned slides using a drop of water or acetone. Sections were 
dried using at hot plate at a temperature of 60-65°C. 
Rehydrated with distilled water for 10 minutes at room 
temperature. 
Antigen was unmasked by incubating with Tris-EDTA-Tween 
buffer + 1% BSA for 15 minutes at room temperature. 
Blocked with normal goat sera for 15 minutes at 32°C. 
Excess goat sera blotted away. 
Primary antibody (rabbit anti-RSV) diluted in TBS was 
applied and incubated overnight at 4°C. 
Rinsed 3 times for 5 minutes each by submersion in 
Tris-EDTA-Tween buffer + 1% BSA at room temperature. 
Secondary antibody (goat anti-rabbit) diluted in TBS was 
applied and incubated for 45 minutes at 32°C. 
Rinsed by submersion 1 time for 5 minutes with 
Tris-EDTA-Tween buffer + 1% BSA then 2 times for 5 minutes 
each with TBS at room temperature. 
ABC reagent Vectastain ABC Kit, Vector Labs, Burlingame, 
GA) applied for 1 hour at 37°C. 
Rinsed once for 5 minutes with Tris-EDTA-Tween buffer then 2 
times for 5 minutes each with TBS at room temperature. 
Incubated with 1% diaminobenzidine in 0.02% ^2^2 10 
minutes at room temperature. 
Rinsed for 10 minutes with running tap water. 
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o) Cotinterstained with Mayer's hematoxylin for 3 minutes. 
Negative controls consisted of substitution of normal rabbit sera 
for primary antibody 
Results: Many sections floated off the slides regardless of water 
or acetone flotation of sections. 
131 
V. Respiratory syncytial virus antigen detection in epoxy embedded 
lung sections on acid cleaned slides using immunoperoxidase. 
Same protocol as used in IV. 
Results: Many sections floated off the slides during the staining 
procedure 
Excessive chromogen trapping within and under the 
treated tissues sections caused excessive background 
staining that prevented recognition of any specific 
staining. 
VI. Respiratory syncytial virus antigen detection in epoxy embedded 
section on poly-L-lysine coated slides. 
a) 1 fim Tissue sections of 1 /xm thickness were floated 
onto poly-L-lysine coated slides. 
b) Remaining protocol identical to that of IV. 
Results: Many sections floated off the slides during the staining 
procedure 
Excessive chromogen trapping within and under the 
treated tissue sections caused excessive background 
staining that prevented recognition of any specific 
staining. 
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In an attempt to maximize viral antigen availability and labeling 
with immttnogold, pre-embedding labeling techniques were attempted. 
VII. Respiratory syncytial virus antigen detection using pre-embedding 
indirect colloidal gold immunocytochemical techniques on infected 
ovine turbinates grown on Millicell-HA membranes (Millipore 
Corp., Bedford, MA.) 
Membranes were fixed in 3% glutaraldehyde in O.IM cacodylate 
buffer for 1 hour then stored in buffer. 
Rinsed by submersion in O.IM cacodylate buffer.^ 
Rinsed by submersion in TBS for 10 minutes. 
Antigen was unmasked by incubation with Tris-EDTA-Tween 
buffer for 10 minutes at room temperature. 
Rinsed 3 times for 5 minutes each with Tris-EDTA-Tween + 1% 
BSA at room temperature . 
Blocked with normal goat sera for 15 minutes at room 
temperature. 
g 
m 
Primary antibody (rabbit anti-RSV) diluted in TBS was applied 
and incubated overnight at 4°C. 
Rinsed 3 times for 5 minutes each with Tris-EDTA-Tween buffer 
+ 1% BSA at room temperature. 
Gold labeled secondary antibody (15 run gold labeled goat 
anti-rabbit) diluted in TBS was applied and incubated for 1 
hour at 37°C. 
Rinsed 3 times for 5 minutes each with Tris-EDTA-Tween buffer 
+ 1% BSA at room temperature . 
Rinsed 3 times for 5 minutes each with TBS at room 
temperature. 
Post-staining fixation with 3% glutaraldehyde in O.IM 
cacodylate buffer and store. 
Processed for transmission electron microscopic examination. 
^ All rinses were carried out by submersion on a rotary platform. 
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Negative controls consisted of non-infected ovine turbinates and 
substitution of normal rabbit sera for primary antibody. 
Results: Staining was non-specific. Gold particles were present 
in low numbers randomly distributed over cellular and 
acellular portions of sections of infected tissues. 
Virions were present in treated tissues and were not 
labeled with gold particles. 
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